We hence conducted pseudotyped virus infection studies in the presence of AMD3100 (CXCR4 antagonist), Maraviroc (CCR5 antagonist) or a combination of both to determine the co-receptor preference of the two Envs. Here, CCR5 is linked to viral infectious disease.